Published in J Biol Chem on May 11, 2001
NF-kappaB activation in melanoma. Pigment Cell Res (2006) 1.55
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. Blood (2008) 1.45
TRAIL in cancer therapy: present and future challenges. Expert Opin Ther Targets (2007) 1.36
Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clin Cancer Res (2007) 1.14
Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol (2015) 1.03
Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer (2003) 1.01
Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors. Free Radic Biol Med (2012) 0.95
Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa. J Virol (2011) 0.93
Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation. Br J Cancer (2003) 0.92
Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model. Int J Nanomedicine (2012) 0.92
TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential. Br J Cancer (2003) 0.90
Alpha-tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells. Br J Cancer (2004) 0.89
Concern Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability. Am J Pathol (2002) 0.88
DAPK2 is a novel modulator of TRAIL-induced apoptosis. Cell Death Differ (2014) 0.88
Role of WWOX and NF-κB in lung cancer progression. Transl Respir Med (2013) 0.79
α-Tocopheryl succinate induces apoptosis in erbB2-expressing breast cancer cell via NF-κB pathway. Acta Pharmacol Sin (2010) 0.77
Screening of a kinase library reveals novel pro-senescence kinases and their common NF-κB-dependent transcriptional program. Aging (Albany NY) (2015) 0.76
Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Res (2015) 0.76
The pro-apoptotic effects of TIPE2 on AA rat fibroblast-like synoviocytes via regulation of the DR5-caspase-NF-κB pathway in vitro. Onco Targets Ther (2016) 0.75
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki disease. Exp Ther Med (2017) 0.75
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol (2001) 1.57
High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell (1993) 1.45
Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci (2000) 1.44
Monoclonal antibodies to lampbrush chromosome antigens of Pleurodeles waltlii. Chromosoma (1985) 1.44
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience (2007) 1.40
Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol Pharmacol (1999) 1.36
Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina. Mol Cell Biol (1993) 1.33
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol (1992) 1.33
Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors. Appl Environ Microbiol (2000) 1.29
Multiple domains for the chicken cellular sequences homologous to the v-ets oncogene of the E26 retrovirus. Mol Cell Biol (1987) 1.20
The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene (2006) 1.13
Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells. Mol Biol Cell (2000) 1.12
ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin. Oncogene (2000) 1.11
Spinal opioid analgesia: how critical is the regulation of substance P signaling? J Neurosci (1999) 1.10
Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J Cell Sci (1995) 1.09
Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res (1994) 1.08
Characterization of a paired box- and homeobox-containing quail gene (Pax-QNR) expressed in the neuroretina. Oncogene (1992) 1.07
The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol Biol Cell (1999) 1.03
Structure and DNA-binding properties of Pax-QNR, a paired box- and homeobox-containing gene. Cell Growth Differ (1993) 1.01
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol (1995) 0.99
CpG motifs induce Langerhans cell migration in vivo. Int Immunol (2000) 0.97
The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ (1997) 0.97
Expression of a functional Fc epsilon RI on rat eosinophils and macrophages. J Immunol (2000) 0.96
Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res (2001) 0.95
Induction of proliferation of neuroretina cells by long terminal repeat activation of the carboxy-terminal part of c-mil. Mol Cell Biol (1987) 0.94
Expression patterns of c-myb and of v-myb induced myeloid-1 (mim-1) gene during the development of the chick embryo. Development (1992) 0.93
Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signaling in the rat. J Neurosci (2001) 0.93
PEA3 transactivates vimentin promoter in mammary epithelial and tumor cells. Oncogene (1996) 0.92
Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus. Blood (1997) 0.92
Two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, cooperate to induce transformation of chicken neuroretina cells. J Virol (1989) 0.91
The relationship between cell proliferation and the transcription of the nuclear oncogenes c-myc, c-myb and c-ets-1 during feather morphogenesis in the chick embryo. Development (1991) 0.89
Morphology, homogeneity and functionality of human monocytes-derived macrophages. Cell Mol Biol (Noisy-le-grand) (2003) 0.89
Heart tumors specifically induced in young avian embryos by the v-myc oncogene. Proc Natl Acad Sci U S A (1987) 0.88
The acentriolar state of the Drosophila cell lines 1182. Biol Cell (1989) 0.88
AMP analogs: their function in the activation of glycogen phosphorylase b. Eur J Biochem (1976) 0.87
p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo. Oncogene (1993) 0.87
The c-ets-1 proto-oncogene is a new early-response gene differentially regulated by cytokines and growth factors in human fibroblasts. Exp Cell Res (1996) 0.86
The differential contribution of capsaicin-sensitive afferents to behavioral and cardiovascular measures of brief and persistent nociception and to Fos expression in the formalin test. Brain Res (1997) 0.85
In situ study of c-myc protein expression during avian development. Development (1989) 0.85
The avian transcription factor c-Rel is expressed in lymphocyte precursor cells and antigen-presenting cells during thymus development. Dev Immunol (1998) 0.84
Development of an ultralow-light-level luminescence image analysis system for dynamic measurements of transcriptional activity in living and migrating cells. Anal Biochem (2000) 0.84
Decoration of microtubules by fluorescently labeled microtubule-associated protein 2 (MAP2) does not interfere with their spatial organization and progress through mitosis in living fibroblasts. Cell Motil Cytoskeleton (1986) 0.83
Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering. Int J Dev Biol (1996) 0.83
Hydrocortisone perturbs the cell proliferation pattern during feather morphogenesis: evidence for disturbance of cephalocaudal orientation. Int J Dev Biol (1992) 0.83
Mechanism of allosteric activation of glycogen phosphorylase probed by the reactivity of essential arginyl residues. Physicochemical and kinetic studies. Biochemistry (1980) 0.82
Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. Int J Dev Biol (1993) 0.82
Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures. Oncogene (2000) 0.81
Glycogen phosphorylase from rabbit skeletal muscle. Differential spectroscopy. Role of different effectors. Biochimie (1974) 0.81
The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein. Biochem J (2000) 0.81
[Biomedical research: the debate on the reduction and emergence concepts]. Ann Biol Clin (Paris) (2005) 0.81
Stabilization of a phosphorylase b active conformation by hydrophobic solvents. FEBS Lett (1978) 0.80
Cooperative effect of v-myc and v-erbA in the chick embryo. Oncogene (1991) 0.79
Mapping by in vitro constructs of the P100gag-mil region, accounting for induction of chicken neuroretina cell proliferation. J Virol (1988) 0.79
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab Invest (1996) 0.79
Invasive tumors induce c-ets1 transcription factor expression in adjacent stroma. Biol Cell (1995) 0.79
The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine. Neuroscience (1997) 0.79
Expression of transcription factor c-Rel and apoptosis occurrence in polydactylous and syndactylous limb buds of the talpid3 mutant chick embryo. Apoptosis (1999) 0.78
The homeobox-containing Engrailed (En-1) product down-regulates the expression of Pax-6 through a DNA binding-independent mechanism. Cell Growth Differ (1997) 0.78
The tyrosine hydroxylase gene is expressed in endoderm and pancreas of early quail embryos. Anat Embryol (Berl) (1994) 0.78
Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features. Int J Oncol (1997) 0.78
Structure and organization of the mouse elk1 gene. Gene (1996) 0.77
Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc. Oncogene (1992) 0.77
[Transcription factors and angiogenesis]. Pathol Biol (Paris) (1999) 0.77
Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat. Brain Res (1997) 0.77
Mechanism of allosteric activation of glycogen phosphorylase probed by the reactivity of essential arginine residues. Identification of an arginine residue involved in the binding of glucose 1-phosphate. Biochemistry (1981) 0.76
cRel induces mitochondrial alterations in correlation with proliferation arrest. Free Radic Biol Med (2001) 0.76
C-Rel: a multifunctional transcription factor ? Cell Death Differ (1994) 0.76
Alternative splicing of RNAs transcribed from the chicken c-mil gene. Mol Cell Biol (1988) 0.76
1,N6-etheno-AMP and 1,N6-etheno-2'-deoxy-AMP as probes of the activator site of glycogen phosphorylase from rabbit skeletal muscle. Proc Natl Acad Sci U S A (1976) 0.75
In vivo cooperation of two nuclear oncogenic proteins, P135gag-myb-ets and p61/63myc, leads to transformation and immortalization of chicken myelomonocytic cells. J Virol (1994) 0.75
[New inhibitors of tumor angiogenesis]. Bull Cancer (1997) 0.75
Conformational changes and local events at the AMP site of glycogen phosphorylase b: a fluorescence temperature-jump relaxation study. Biochemistry (1978) 0.75
Oncogenes and the control of cell growth: fitting together the pieces of the puzzle. Biochimie (1987) 0.75
[Transcription factors of the Ets family and morphogenesis of the vascular tree]. J Soc Biol (1999) 0.75
[Chemical reactivity of an essential arginine residue in substrate binding, reflecting the state of activation of glycogen phosphorylase in rabbit muscle]. C R Seances Acad Sci D (1979) 0.75
[Experimental angiogenesis : strategy for the functional study of the transcription factors of the Ets family during morphogenesis of the vascular tree]. Ann Endocrinol (Paris) (2000) 0.75
Maternal perinatal undernutrition impairs chromaffin cells proliferation in the postnatal rat. Horm Metab Res (2008) 0.75
The reactivity of arginine residues interacting with glucose 1-phosphate in glycogen phosphorylase. A comparison between pyridoxal-reconstituted phosphorylase and the native enzyme. Eur J Biochem (1983) 0.75
[Therapeutic prospects of angiogenesis inhibitors in cancerology]. Rev Mal Respir (1999) 0.75
Schistosome-derived inhibitory factor: an immunosuppressive agent preferentially active on T lymphocytes. Int Arch Allergy Appl Immunol (1986) 0.75
[Experimental models of angiogenesis for the study of the Ets1 transcription factor]. Therapie (1998) 0.75
The avian transcription factor c-Rel is induced and translocates into the nucleus of thymocytes undergoing apoptosis. Cell Death Differ (1997) 0.75
The temperature jump relaxation technique. Biochimie (1975) 0.75
Neoplastic AIDS-associated Kaposi's sarcoma cell line KSY-1 cannot transdifferentiate into capillaries. J Hum Virol (1999) 0.75